N/A N=359 Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement
Asthma
Primary: Number of Participants Achieving Asthma Control — 121; 128; 53; 36 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=115 Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
Sleep Apnea
Primary: Apnea-hypopnea Indices (AHI) as Determined by Polysomnography (PSG) vs Automatic Event Detection (AED ) Algorithm — 5.6; 5.8; 2.4; 3.2 events per hour — p=0.007
Phase 3 N=200 Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Malaria
Primary: Number of Subjects With Serious Adverse Events (SAEs) — 41; 37; 41; 37 Participants
N/A N=58 An Implant With an Acid-etched Fixture Surface and Internal-hex Collar May Achieve Greater Osseointegration.
Jaw, Edentulous · Dental Implant
Primary: Comparison of Quantitative Bone Healing — -1.18; -1.01; -0.91 mm — p=<0.05
Phase 2 N=59 Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer
Head and Neck Neoplasms · Mucositis
Primary: Incidence of Severe OM During Radiation Therapy in Subjects Receiving a Cumulative IMRT Dose of at Least 55 Gy — 15; 9; 10; 12 Participants
Phase 1 N=36 Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan
Non-alcoholic Fatty Liver Disease
Primary: Area Under the Plasma Concentration-time Curve From 0 to Time of Last Quantifiable Time Point (tz) of Total Dabigatran (AUC0-tz). — 667; 192 Nanogram*Hour/ millilitre…
N/A N=70 The Clinical Comparison of Narafilcon A and Stenfilcon A Contact Lenses
Myopia
Primary: Ocular Physiology — 0.84; 0.76; 0.75; 0.62 units on a scale
N/A N=246 Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>
Type 2 Diabetes Mellitus
Primary: Percentage of Participants Achieving Good Glycemic Control (Reduction in Fasting Blood Glucose Level < 130 mg/dL) — 42.2 Percentage of Participants
N/A N=21 Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies
Neonatal Abstinence Syndrome
Primary: Number of Participants With Skin Breakdown and / or Cellulitis — 0 participants
Phase 3 N=291 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Scabies
Primary: Number of Index Subjects Completely Cured of Scabies After a Single Treatment — 30; 20 Participants
N/A N=8 Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration
End-stage Renal Disease
Primary: Removal of Para-cresylsulfate — 42.0; 32.6; 33.6 percentage of reduction
Phase 3 N=280 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Scabies
Primary: Number of Index Subjects Completely Cured of Scabies After a Single Treatment — 52; 20 Participants
Phase 1 N=18 Study of SHP620 (Maribavir) in Healthy Adults
Cytomegalovirus (CMV)
Primary: Maximum Observed Plasma Concentration (Cmax) of Digoxin — 1.94; 2.35 Nanogram per milliliter (ng/mL)
N/A N=84 Endotracheal Tube Intracuff Pressure and Leak
Otolaryngological Surgery
Primary: Changes in the Intracuff Pressure — 3 cmH2O
Phase 3 N=148 Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
Asthma
Primary: Trough FEV1 After One Week of Treatment, Point Estimate — 2.392; 2.392; 2.303 Liters — p=<0.001